Iain D. Dukes - 01 Nov 2024 Form 4 Insider Report for Lomond Therapeutics Holdings, Inc.

Reporting relationship: CEO and Chairman, Director
Issuer ticker: N/A
Reported as of: 01 Nov 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Nov 2024, 18:00:12 UTC
Prior SEC filing: 13 Jun 2024
Next SEC filing: 17 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Iain D. Dukes

Key filing fact

Iain D. Dukes filed Form 4 for Lomond Therapeutics Holdings, Inc. on 05 Nov 2024.

Key facts

This page summarizes Iain D. Dukes's Form 4 filing for Lomond Therapeutics Holdings, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Nov 2024, 18:00.

Change

Previous filing in this sequence was filed on 13 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

No ticker transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +2,096,667
Change %
Price: $0.000000
Shares after: 2,096,667
Date: 01 Nov 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,096,667
Exercise price: $1.30
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/48th of the options vesting monthly after November 1, 2024, subject to the Reporting Person's continuous service with the Issuer through each such vesting date.